| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/08/2004 | US20040067875 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 04/08/2004 | US20040067874 Antidiabetic agents; genetic engineered polypeptide |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067556 Growth differentiation factor-6 |
| 04/08/2004 | US20040067554 Nucleotide sequences of moraxella catarrhalis genome |
| 04/08/2004 | US20040067553 Membrane protein for diagnosis and treatment of nervous system, endocrine, metabolic, cancer, inflamatory, respiratory, immune and infectious diseases |
| 04/08/2004 | US20040067552 Adipocyte complement related protein zacrp14 |
| 04/08/2004 | US20040067544 Invention shows that shear-induced mechanical force enhances strength of receptor-specific interactions between adhesion molecules such as FimH and target cells, and this phenomenon is dependent on structural properties of adhesion molecules |
| 04/08/2004 | US20040067524 Chlamydia protein, gene sequence and uses thereof |
| 04/08/2004 | US20040067523 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/08/2004 | US20040067520 Given DNA sequence; Fc immunoglobulin region attached; transforming cell; use in treating obesity |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067517 Of given amino acid sequence; binds with antibodies to the causative agent; expressed by spirochetes of Borrelia burgdorferi |
| 04/08/2004 | US20040067516 Using a cDNA library to identify the expressed sequence; antibodies and inhibitory compounds to prevent infestation of animals |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067506 Novel root specific promoter driving the expression of a novel lrr receptor-like kinase |
| 04/08/2004 | US20040067505 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067500 Compositions and methods relating to the peroxisomal proliferator activated receptor-alpha mediated pathway |
| 04/08/2004 | US20040067499 Novel g protein-coupled receptor |
| 04/08/2004 | US20040067491 Diagnosis of diseases associated with metabolism |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067486 Nucleic acid containing one or more adaptive mutations, and Hepatitis c Virus (HCV) replicon enhanced cells ( cells having an increased ability to maintain an HCV replicon) |
| 04/08/2004 | US20040067240 Therapeutic agent comprising a b-subunit of a protein toxin |
| 04/08/2004 | US20040067239 Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof |
| 04/08/2004 | US20040067238 Novel compounds |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |
| 04/08/2004 | US20040067226 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis or prevention of vision defects |
| 04/08/2004 | US20040067217 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 04/08/2004 | US20040066199 Determination structure and voltage dependency; analyzing cell membranes; drug design |
| 04/08/2004 | CA2540354A1 Nuclear receptor transcriptional corepressor and uses thereof |
| 04/08/2004 | CA2539622A1 Anti-hla assay and methods |
| 04/08/2004 | CA2502735A1 Targeted cd1d molecules |
| 04/08/2004 | CA2500318A1 Regulation of human p2y15 g protein-coupled receptor |
| 04/08/2004 | CA2500254A1 Method for designing peptides |
| 04/08/2004 | CA2500248A1 Peptide derivative fusion inhibitors of hiv infection |
| 04/08/2004 | CA2500234A1 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p 7 |
| 04/08/2004 | CA2500123A1 Method for producing acylated peptides |
| 04/08/2004 | CA2500040A1 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 04/08/2004 | CA2500021A1 Modified glp-1 peptides with increased biological potency |
| 04/08/2004 | CA2499972A1 Method for inducing mammary epithelial cell differentiation |
| 04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499623A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499580A1 Novel agents that modulate eph receptor activity |
| 04/08/2004 | CA2499042A1 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | CA2497767A1 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 04/08/2004 | CA2494899A1 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | CA2485970A1 Methods for diagnosing htlv-i-mediated diseases |
| 04/07/2004 | EP1405923A2 Gene mapping method using microsatellite genetic polymorphism markers |
| 04/07/2004 | EP1405916A1 Recombinant vaccinia virus incapable of expressing the A41L gene |
| 04/07/2004 | EP1405915A1 IL-4 trap based on IL receptor fusion proteins |
| 04/07/2004 | EP1405913A2 Process for improving the production of 5R clavams |
| 04/07/2004 | EP1405911A1 Interaction trap systems for detecting protein interactions |
| 04/07/2004 | EP1405863A1 Concentrate of a factor VIII:C-containing von-Willebrand-factor and a process for producing it |
| 04/07/2004 | EP1405862A2 Method for the identification of antigenic peptides |
| 04/07/2004 | EP1405861A2 Analogs of parathyroid hormone |
| 04/07/2004 | EP1405643A1 Acellular pertussis vaccines and methods of preparation thereof |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1405079A2 Modulation of the interaction between evh1 domains |
| 04/07/2004 | EP1405078A1 Method for determining the nature of an infection |
| 04/07/2004 | EP1405077A2 Carcinoma-related peptides |
| 04/07/2004 | EP1404877A2 New assays for preimplantation factor and preimplantation factor peptides |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404872A2 Method of selecting a dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 04/07/2004 | EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels |
| 04/07/2004 | EP1404870A2 Function and application of tob gene in central nervous system of mammal |
| 04/07/2004 | EP1404867A2 Oligonucleotide transfection screening method |
| 04/07/2004 | EP1404865A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 04/07/2004 | EP1404859A2 Proteins that regulate systemic acquired resistance in plants |
| 04/07/2004 | EP1404858A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/07/2004 | EP1404845A2 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 04/07/2004 | EP1404842A2 Perv screening method and use thereof |
| 04/07/2004 | EP1404834A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 04/07/2004 | EP1404833A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/07/2004 | EP1404832A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404825A2 A WALK-THROUGH TECHNIQUE FOR i IN VITRO /i RECOMBINATION OF POLYNUCLEOTIDE SEQUENCES |
| 04/07/2004 | EP1404816A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 04/07/2004 | EP1404814A2 Nuclear fertility restorer genes and methods of use in plants |
| 04/07/2004 | EP1404808A2 Nucleic acid free ghost preparations |
| 04/07/2004 | EP1404807A2 20 human secreted proteins |
| 04/07/2004 | EP1404806A1 Male contraceptives |
| 04/07/2004 | EP1404718A2 Inhibitors of memapsin 2 and use thereof |
| 04/07/2004 | EP1404717A1 Kinetic assay |
| 04/07/2004 | EP1404716A2 Novel g protein-coupled receptors and dna sequences thereof |
| 04/07/2004 | EP1404715A2 Modified cd8 molecule, nucleic acid encoding said molecule, and their therapeutic use |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404713A1 Novel keratinocyte growth factor-2 analogue in hair follicle |
| 04/07/2004 | EP1404711A2 Mutated photoproteins and their uses |
| 04/07/2004 | EP1404710A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 04/07/2004 | EP1404709A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/07/2004 | EP1404708A2 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1 |
| 04/07/2004 | EP1404706A2 Mycobacterial antigens expressed during latency |
| 04/07/2004 | EP1404705A1 Compositions and methods of using hiv vpr |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404702A2 Human secreted proteins |
| 04/07/2004 | EP1404428A1 Methods for purifying highly anionic proteins |
| 04/07/2004 | EP1404377A2 Improved chelator conjugates |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404368A2 Mutant forms of cholera holotoxin as an adjuvant |